Education
About Us
Working with TipRanks
Follow Us
Cidara Therapeutics (CDTX)
NASDAQ:CDTX
RESEARCH TOOLSreports
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 63.91M | $ 64.29M | $ 49.57M | $ 12.07M | $ 20.91M |
| Gross Profit | $ 62.38M | $ 64.14M | $ 49.38M | $ -55.95M | $ -25.49M |
| Operating Income | $ -24.48M | $ -29.72M | $ -42.26M | $ -71.85M | $ -41.72M |
| EBITDA | $ -24.36M | $ -33.36M | $ -42.26M | $ -71.56M | $ -41.40M |
| Net Income | $ -22.93M | $ -29.80M | $ -43.91M | $ -72.37M | $ -40.09M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 35.78M | $ 32.73M | $ 62.27M | $ 35.91M | $ 60.27M |
| Total Assets | $ 67.03M | $ 47.59M | $ 75.33M | $ 60.42M | $ 68.98M |
| Total Debt | $ 4.88M | $ 1.32M | $ 5.06M | $ 7.96M | $ 11.72M |
| Net Debt | $ -30.90M | $ -31.41M | $ -57.21M | $ -27.95M | $ -48.54M |
| Total Liabilities | $ 75.24M | $ 50.50M | $ 53.75M | $ 49.71M | $ 31.14M |
| Stockholders' Equity | $ -8.21M | $ -2.90M | $ 21.57M | $ 10.71M | $ 37.84M |
| Cash Flow | |||||
| Free Cash Flow | $ -22.94M | $ -28.59M | $ -25.27M | $ -54.60M | $ -28.57M |
| Operating Cash Flow | $ -22.43M | $ -28.47M | $ -25.23M | $ -54.41M | $ -28.53M |
| Investing Cash Flow | $ -505.00K | $ -118.00K | $ -41.00K | $ -186.00K | $ -35.00K |
| Financing Cash Flow | $ 25.98M | $ -951.00K | $ 44.60M | $ 37.28M | $ 14.27M |